Evolva (EVE)

Business description

Evolva is a Swiss high tech fermentation company. It has a proprietary yeast technology platform, which it uses to create and manufacture high-value speciality molecules for nutritional and consumer products.

Stock data

Market cap.CHF227.6m
Last closeCHF0.57
High / Low (52 weeks)CHF0.9 / CHF0.4
Stock market listingSW
Forecast net cash (CHFm)47.5
Forecast gearing ratio (%)N/A
TeamConsumer
SectorFood & Drink

Price performance

%1m3m12m
Actual0.0(9.5)(38)
Relative *(1)(13.5)(44.1)

* % Relative to local index

Other companies in sector Show

Company news

Evolva to Acquire Allylix

Tue, 18 Nov 2014 06:01:29 GMT

Stevia from fermentation will be available next year, says Evolva

Tue, 10 Feb 2015 11:33:26 GMT

Evolva Holding SA (SWX:EVE): Technical Valuation Breakdown

Sat, 11 Mar 2017 21:56:15 GMT

Evolva Provides Update on Stevia Collaboration and 2016 Preliminary Top-Line ...

Tue, 10 Jan 2017 05:48:45 GMT

Cargill Develops New Stevia-Like Sweetener Without Plants

Thu, 01 Oct 2015 10:03:07 GMT

Y/E Dec Revenue (CHFm) EBITDA (CHFm) PBT (CHFm) EPS (CHF) P/E (x) P/CF (x)
2014A 10.7 (19.4) (21.2) (6.4) N/A N/A
2015A 13.4 (30.3) (32.1) (8.0) N/A N/A
2016E 9.6 (31.4) (32.2) (8.1) N/A N/A
2017E 14.9 (30.1) (31.4) (7.7) N/A N/A

Last updated on 16/03/2017

Latest research

Headroom improves

Update | Food & Drink | 16/03/2017

A cloudier picture

Update | Food & Drink | 16/01/2017

On track

Update | Food & Drink | 01/09/2016

Positive stevia newsflow

Update | Food & Drink | 07/06/2016

Stevia delayed

Update | Food & Drink | 06/04/2016

Tastes good

Outlook | Food & Drink | 15/01/2016

Getting sweeter

QuickView | Food & Drink | 19/11/2015

Rights issue supports stevia JV

Update | Food & Drink | 07/09/2015

Manufacturing a sweeter future

Update | Pharmaceutical & healthcare | 18/05/2015

Daily comment

Institutional Comment | Pharmaceutical & healthcare | 11/02/2015

Gaining dominance

Update | Pharmaceutical & healthcare | 11/02/2015

Prepared for the stevia JV

Update | Pharmaceutical & healthcare | 10/03/2014

Investment summary

Evolva has secured equity financing of up to CHF30m. This is a fully flexible arrangement with relatively good terms, which if drawn down in full would give the company about one year’s worth of cash. As an interim arrangement this allows headroom to increase considerably and should help management’s negotiating position with its partner, Cargill, as details of the stevia JV are yet to be agreed. Our valuation of CHF0.87/share remains unchanged.

Last updated on 16/03/2017

Industry outlook

The manufacturers of nutritional and consumer health products are always interested in cheaper production methods, especially if the product is natural and has health benefits. Evolva is primarily targeting this market.

Last updated on 02/03/2017

Key management

Sir Tom McKillop, Chairman
Neil Goldsmith, CEO
Oliver Walker, CFO

Company address

Duggingerstrasse. 23
Reinach
CH-4153
Switzerland
+41 61 485 2000
View website